Trade Gilead ^GILD

Gilead Sciences (GILD) to Release Quarterly Earnings on Tuesday

Principal Financial Group Inc. Trims Holdings in Gilead Sciences, Inc. $GILD

Gilead Sciences Oncology Push Gains Traction With Trodelvy Keytruda Results

Gilead's Growing Oncology Role Reshapes The Investment Case For GILD

Nurix Therapeutics, Inc. (NRIX): A Bull Case Theory - Insider Monkey

Gilead Sciences, Inc. (GILD): A Bull Case Theory

Tailoring targeted therapies for younger women with ER-positive early-stage breast cancer

TIGIT Inhibitors Market Poised for Strong Growth Through 2034, Driven by Expanding Immuno-Oncology Pipeline | DelveInsight

Best Pharmaceutical Stocks To Watch Today - February 1st - Markets Daily

Gilead Sciences (NASDAQ:GILD) Sets New 12-Month High on Analyst Upgrade

Gilead Sciences, Inc. $GILD Position Cut by TD Waterhouse Canada Inc.

Gilead Sciences, Inc. $GILD Stake Lessened by Convergence Investment Partners LLC

Truist Securities Raises Price Target on Gilead Sciences, Inc. (GILD) to $145, Keeps Buy Rating

Top Pharmaceutical Stocks To Add to Your Watchlist - January 31st - Markets Daily

Mediolanum International Funds Ltd Buys 9,971 Shares of Gilead Sciences, Inc. $GILD

Thrivent Financial for Lutherans Boosts Stake in Gilead Sciences, Inc. $GILD

AE Wealth Management LLC Buys 8,554 Shares of Gilead Sciences, Inc. $GILD

UBS Turns More Bullish on Gilead Sciences, Inc. (GILD) Amid Positive Pharma Sector Outlook

Gilead Sciences (NASDAQ:GILD) Price Target Raised to $146.00 at Leerink Partners

10,471 Shares in Gilead Sciences, Inc. $GILD Acquired by Winnow Wealth LLC

Safety and biologic activity of a bispecific T cell receptor targeting HIV Gag in males living with HIV: a first-in-human trial

TD Cowen Forecasts Strong Price Appreciation for Gilead Sciences (NASDAQ:GILD) Stock - Markets Daily

Truist Financial Corp Has $34.45 Million Position in Gilead Sciences, Inc. $GILD - Zolmax

Gilead Sciences (NASDAQ:GILD) CEO Daniel Patrick O'day Sells 10,000 Shares of Stock - Markets Daily

Gilead Sciences (NASDAQ:GILD) Stock Price Expected to Rise, TD Cowen Analyst Says - Stock Observer

Gilead Sciences, Inc. $GILD Holdings Lifted by Foundations Investment Advisors LLC

Patton Albertson Miller Group LLC Purchases Shares of 7,460 Gilead Sciences, Inc. $GILD - Daily Political

Insider Selling: Gilead Sciences (NASDAQ:GILD) CEO Sells 10,000 Shares of Stock

Chronic Hepatitis D Market Poised for Significant Growth During the Forecast Period (2025-2034) as Emerging Therapies Drive Optimism | DelveInsight

Wolfe Research Issues Positive Forecast for Gilead Sciences (NASDAQ:GILD) Stock Price

Ruffer LLP Raises Stake in Gilead Sciences, Inc. $GILD

Mirae Asset Global Investments Co. Ltd. Grows Stake in Gilead Sciences, Inc. $GILD - Markets Daily

Gilead Sciences, Inc. $GILD is AustralianSuper Pty Ltd's 9th Largest Position

New York State Common Retirement Fund Sells 89,400 Shares of Gilead Sciences, Inc. $GILD - Stock Observer

Gilead Sciences (NASDAQ:GILD) Hits New 1-Year High Following Analyst Upgrade - Stock Observer

Federated Hermes Inc. Sells 324,814 Shares of Gilead Sciences, Inc. $GILD

Federated Hermes Inc. Has $294.80 Million Holdings in Gilead Sciences, Inc. $GILD - Daily Political

US Government Targets Major HIV and Arthritis Drugs for Medicare Price Negotiations in 2028, ETPharma

Gilead Sciences (GILD) Is Up 11.0% After Trodelvy Combo Outperforms Keytruda Chemo In Phase 3 Trial - Has The Bull Case Changed?

Gilead's Trodelvy Data Sparks Questions On Valuation And Oncology Growth

Gilead Sciences (NASDAQ:GILD) Price Target Raised to $145.00

Citigroup Increases Gilead Sciences (NASDAQ:GILD) Price Target to $156.00

Gilead Sciences (NASDAQ:GILD) Reaches New 12-Month High Following Analyst Upgrade

Kornitzer Capital Management Inc. KS Reduces Holdings in Gilead Sciences, Inc. $GILD - Daily Political

Top Pharmaceutical Stocks To Keep An Eye On - January 26th - Markets Daily

Gilead Sciences (NASDAQ:GILD) Price Target Raised to $155.00

Gilead Sciences (NASDAQ:GILD) Stock Price Expected to Rise, UBS Group Analyst Says - Zolmax

Gilead Sciences (NASDAQ:GILD) Price Target Raised to $150.00 at BMO Capital Markets

Gilead Sciences, Inc. $GILD Shares Sold by AEGON ASSET MANAGEMENT UK Plc

Gilead Sciences, Inc. $GILD is Sector Gamma AS's 9th Largest Position

AMF Tjanstepension AB Reduces Holdings in Gilead Sciences, Inc. $GILD

Medical Stocks Worth Watching - January 24th - Markets Daily

Mn Services Vermogensbeheer B.V. Acquires 8,500 Shares of Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. $GILD Shares Sold by Resona Asset Management Co. Ltd.

UniSuper Management Pty Ltd Has $62.38 Million Stake in Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. $GILD Shares Acquired by Envestnet Portfolio Solutions Inc.

UniSuper Management Pty Ltd Acquires 15,479 Shares of Gilead Sciences, Inc. $GILD - Stock Observer

Teacher Retirement System of Texas Sells 28,085 Shares of Gilead Sciences, Inc. $GILD - Stock Observer

Gilead Sciences (NASDAQ:GILD) Downgraded by Wall Street Zen to Buy

Best Medical Stocks To Keep An Eye On - January 23rd - Markets Daily

MOKAN Wealth Management Inc. Trims Position in Gilead Sciences, Inc. $GILD

Strs Ohio Purchases 24,284 Shares of Gilead Sciences, Inc. $GILD

Rakuten Investment Management Inc. Purchases New Shares in Gilead Sciences, Inc. $GILD - Markets Daily

Top Pharmaceutical Stocks To Watch Now - January 23rd - Daily Political

Grandfield & Dodd LLC Sells 20,655 Shares of Gilead Sciences, Inc. $GILD

Vest Financial LLC Acquires 6,019 Shares of Gilead Sciences, Inc. $GILD - Stock Observer

GILD: Extended HIV Franchise Strength Will Support Stronger Long-Term Earnings Power

CapWealth Advisors LLC Lowers Position in Gilead Sciences, Inc. $GILD

Gilead Sciences (NASDAQ:GILD) Director Jeffrey Bluestone Sells 5,000 Shares - Stock Observer

Analysts Conflicted on These Healthcare Names: Insulet (PODD) and Gilead Sciences (GILD) | Markets Insider

Jeffrey Bluestone Sells 5,000 Shares of Gilead Sciences (NASDAQ:GILD) Stock

Gilead Sciences (NASDAQ:GILD) Reaches New 12-Month High After Analyst Upgrade - Markets Daily

Rothschild & Co Redburn Issues Positive Forecast for Gilead Sciences (NASDAQ:GILD) Stock Price

Gilead Sciences (GILD) Valuation Check After Recent Share Price Softness

Gilead's Yeztugo Approval Highlights HIV Growth And Acquisition-Fueled Upside

Bernstein Remains a Buy on Gilead Sciences (GILD) | Markets Insider

Gilead Sciences, Inc. $GILD Shares Acquired by Wealth Enhancement Advisory Services LLC

Royal Bank Of Canada Forecasts Strong Price Appreciation for Gilead Sciences (NASDAQ:GILD) Stock

Triasima Portfolio Management inc. Grows Position in Gilead Sciences, Inc. $GILD - Daily Political

Tradewinds LLC. Takes $507,000 Position in Gilead Sciences, Inc. $GILD - Markets Daily

Mika Yamakawa Recognized With "Excellence In Healthcare Award" At Health 2.0 Conference, 2025 Edition

Gilead Sciences, Inc. (NASDAQ:GILD) Given Average Rating of "Moderate Buy" by Brokerages

Tradewinds LLC. Purchases New Position in Gilead Sciences, Inc. $GILD - Stock Observer

Allstate Corp Grows Position in Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. $GILD Shares Sold by QRG Capital Management Inc.

Andrew Dickinson Sells 3,000 Shares of Gilead Sciences (NASDAQ:GILD) Stock

Ritholtz Wealth Management Increases Stock Position in Gilead Sciences, Inc. $GILD - Markets Daily

Gilead Sciences, Inc. $GILD Shares Purchased by Ritholtz Wealth Management - Stock Observer

Morgan Stanley Cuts Gilead Sciences (NASDAQ:GILD) Price Target to $150.00 - Daily Political